1. Home
  2. NOTV vs DLNG Comparison

NOTV vs DLNG Comparison

Compare NOTV & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • DLNG
  • Stock Information
  • Founded
  • NOTV 1974
  • DLNG 2013
  • Country
  • NOTV United States
  • DLNG Greece
  • Employees
  • NOTV N/A
  • DLNG N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • DLNG Marine Transportation
  • Sector
  • NOTV Health Care
  • DLNG Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • DLNG Nasdaq
  • Market Cap
  • NOTV 137.5M
  • DLNG 143.7M
  • IPO Year
  • NOTV 1997
  • DLNG 2013
  • Fundamental
  • Price
  • NOTV $1.96
  • DLNG $3.73
  • Analyst Decision
  • NOTV Strong Buy
  • DLNG
  • Analyst Count
  • NOTV 3
  • DLNG 0
  • Target Price
  • NOTV $6.25
  • DLNG N/A
  • AVG Volume (30 Days)
  • NOTV 840.6K
  • DLNG 45.3K
  • Earning Date
  • NOTV 05-07-2025
  • DLNG 06-26-2025
  • Dividend Yield
  • NOTV N/A
  • DLNG 2.64%
  • EPS Growth
  • NOTV N/A
  • DLNG 59.08
  • EPS
  • NOTV N/A
  • DLNG 1.05
  • Revenue
  • NOTV $480,402,000.00
  • DLNG $156,403,000.00
  • Revenue This Year
  • NOTV $5.84
  • DLNG N/A
  • Revenue Next Year
  • NOTV $5.74
  • DLNG $0.37
  • P/E Ratio
  • NOTV N/A
  • DLNG $3.41
  • Revenue Growth
  • NOTV N/A
  • DLNG N/A
  • 52 Week Low
  • NOTV $1.15
  • DLNG $3.18
  • 52 Week High
  • NOTV $6.48
  • DLNG $5.65
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 47.15
  • DLNG 57.27
  • Support Level
  • NOTV $1.75
  • DLNG $3.50
  • Resistance Level
  • NOTV $2.36
  • DLNG $3.68
  • Average True Range (ATR)
  • NOTV 0.18
  • DLNG 0.17
  • MACD
  • NOTV 0.07
  • DLNG 0.05
  • Stochastic Oscillator
  • NOTV 45.95
  • DLNG 100.00

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About DLNG Dynagas LNG Partners LP Common Units

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.

Share on Social Networks: